CRIS Current Research Information System

BOLONDI, LUIGI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.986
AS - Asia 16.321
EU - Europa 13.420
AF - Africa 1.047
SA - Sud America 949
Continente sconosciuto - Info sul continente non disponibili 28
OC - Oceania 26
Totale 51.777
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.805
VN - Vietnam 5.118
SG - Singapore 4.303
CN - Cina 3.781
GB - Regno Unito 3.433
IT - Italia 1.838
DE - Germania 1.826
SE - Svezia 1.503
HK - Hong Kong 1.065
FR - Francia 940
UA - Ucraina 799
IN - India 780
RU - Federazione Russa 756
BR - Brasile 637
IE - Irlanda 537
NL - Olanda 376
FI - Finlandia 336
ZA - Sudafrica 321
JP - Giappone 304
EE - Estonia 259
TG - Togo 256
CH - Svizzera 243
CI - Costa d'Avorio 216
BG - Bulgaria 139
JO - Giordania 137
KR - Corea 131
PH - Filippine 114
CA - Canada 107
AR - Argentina 106
SC - Seychelles 95
BE - Belgio 85
BD - Bangladesh 79
NG - Nigeria 70
TH - Thailandia 70
EC - Ecuador 67
ID - Indonesia 63
IQ - Iraq 62
PL - Polonia 57
MX - Messico 51
AT - Austria 48
GR - Grecia 42
ES - Italia 40
IR - Iran 39
TW - Taiwan 39
TR - Turchia 37
CL - Cile 36
HR - Croazia 33
PK - Pakistan 30
RO - Romania 30
CO - Colombia 29
UZ - Uzbekistan 25
LT - Lituania 24
SA - Arabia Saudita 24
EU - Europa 21
PE - Perù 20
LB - Libano 19
MA - Marocco 19
MY - Malesia 19
AU - Australia 16
PY - Paraguay 16
VE - Venezuela 16
HU - Ungheria 14
EG - Egitto 13
AE - Emirati Arabi Uniti 12
UY - Uruguay 12
KE - Kenya 11
OM - Oman 11
MK - Macedonia 10
ET - Etiopia 9
AM - Armenia 8
TN - Tunisia 8
BO - Bolivia 7
CR - Costa Rica 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
IL - Israele 7
NP - Nepal 7
NZ - Nuova Zelanda 7
KZ - Kazakistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AL - Albania 5
DZ - Algeria 5
NO - Norvegia 5
PT - Portogallo 5
RS - Serbia 5
AZ - Azerbaigian 4
DK - Danimarca 4
MD - Moldavia 4
MU - Mauritius 4
SI - Slovenia 4
SN - Senegal 4
SY - Repubblica araba siriana 4
BA - Bosnia-Erzegovina 3
BH - Bahrain 3
CG - Congo 3
GE - Georgia 3
GH - Ghana 3
QA - Qatar 3
SK - Slovacchia (Repubblica Slovacca) 3
SR - Suriname 3
Totale 51.732
Salva come PNG Salva come JPEG
Città #
Southend 3.061
Singapore 2.955
Ashburn 2.128
Fairfield 2.111
Chandler 1.501
Dong Ket 1.265
Houston 1.016
Hong Kong 1.004
Wilmington 993
Woodbridge 982
Ho Chi Minh City 926
San Jose 892
Seattle 889
Hanoi 785
Santa Clara 763
Ann Arbor 731
Cambridge 684
Princeton 676
Dublin 534
Jacksonville 521
Beijing 480
Boardman 412
Lauterbourg 338
Bologna 319
Westminster 312
Nanjing 309
Helsinki 296
Hefei 280
Padova 274
Tokyo 266
Lomé 256
Munich 254
Los Angeles 248
Berlin 217
Abidjan 216
Bern 213
Jinan 162
Saint Petersburg 159
New York 153
Buffalo 151
Dallas 144
Shenyang 141
Haiphong 140
Sofia 139
Amman 135
Da Nang 135
Milan 119
Nanchang 118
Guangzhou 108
San Diego 108
Changsha 106
Frankfurt am Main 105
Medford 103
Turin 103
Shanghai 96
Hebei 94
Redondo Beach 91
Mülheim 85
Tianjin 84
Brussels 79
Seoul 78
Florence 76
Dearborn 75
Zhengzhou 70
Abeokuta 66
São Paulo 61
Chicago 58
Jiaxing 58
Rome 51
Bremen 50
Falls Church 50
Mahé 50
Des Moines 48
London 48
Ningbo 47
Redmond 46
Norwalk 45
Council Bluffs 44
Olalla 44
Hangzhou 43
Redwood City 43
The Dalles 43
Toronto 43
Hải Dương 42
Phoenix 42
Amsterdam 41
Orem 41
Can Tho 39
Falkenstein 37
Yubileyny 36
Haikou 35
Wuhan 35
Paris 34
Johannesburg 33
Thái Nguyên 33
Verona 33
Bühl 32
Biên Hòa 31
Mountain View 31
Kunming 30
Totale 33.807
Salva come PNG Salva come JPEG
Nome #
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 478
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 424
Molecular Adsorbent Recirculating System (MARS) application in liver failure: Clinical and hemodepurative results in 22 patients 401
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 360
Efficacy of radioembolization according to tumor morphology and portal vein thrombosis inintermediate-advanced hepatocellular carcinoma 313
Impiego del MARS nell'insufficienza epatica: efficacia depurativa e risultati clinici in 22 pazienti 304
Clinical trial: peg-interferon alfa-2b and ribavirin for the treatment of genotype-1 hepatitis C recurrence after liver transplantation 303
A modeling study of bilirubin kinetics during Molecular Adsorbent Recirculating System sessions. 284
Differences in liver stiffness values obtained with new ultrasound elastography machines and Fibroscan: A comparative study 283
Laser ablation is superior to TACE in large-sized hepatocellular carcinoma: A pilot case-control study 280
Circulating microRNAs, MIR-939, MIR-595, MIR-519d and MIR-494, identify cirrhotic patients with HCC 277
A phase I study of continuous hepatic arterial infusion of Irinotecan in patients with locally advanced hepatocellular carcinoma. 261
Accuracy of VirtualTouch Acoustic Radiation Force Impulse (ARFI) imaging for the diagnosis of cirrhosis during liver ultrasonography 259
In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis 257
Clinical Impact and Safety of Anticoagulants for Portal Vein Thrombosis in Cirrhosis 257
A new priority policy for patients with hepatocellular carcinoma awaiting liver transplantation within the model for end-stage liver disease system. 254
Evaluation of the impact of transient interruption of antiangiogenic treatment using ultrasound-based techniques in a murine model of hepatocellular carcinoma 250
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis. 249
Ablazione percutanea ecoguidata mediante radiofrequenza di piccoli noduli di HCC: fattori correlati all'esito clinico e alla recidiva di malattia 244
Adherence to AASLD guidelines for the treatment of hepatocellular carcinoma in clinical practice: experience of the Bologna Liver Oncology Group. 237
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 234
Aberrant Notch3 and Notch4 expression in human hepatocellular carcinoma. 229
MiR-30e-3p influences tumor phenotype through MDM2/TP53 axis and predicts sorafenib resistance in hepatocellular carcinoma 223
Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis 222
Use of perfusional angiosonography in liver transplantation and conservative management of post-transplant intra-hepatic pseudo-aneurysm. 221
Analysis of risk factors for tumor recurrence after liver transplantation for hepatocellular carcinoma: key role of immunosuppression. 221
LncRNAs as novel players in hepatocellular carcinoma recurrence 221
Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted? 218
Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. 216
Usefulness of contrast-enhanced perfusional sonography in the assessment of hepatocellular carcinoma hypervascular at spiral computed tomography. 216
A new mathematical model for bilirubin kinetics during MARS sessions 216
Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma. 216
Criteria for diagnosing benign portal vein thrombosis in the assessment of patients with cirrhosis and hepatocellular carcinoma for liver transplantation. 213
Nozioni di ecografia Doppler e color-Doppler 211
Venom from Cuban Blue Scorpion has tumor activating effect in hepatocellular carcinoma 211
Use of VEGFR-2 Targeted Ultrasound Contrast Agent for the Early Evaluation of Response to Sorafenib in a Mouse Model of Hepatocellular Carcinoma. 211
Reliability of imaging techniques in assessing portal venous thrombosis in patients with hepatocellular carcinoma candidates for liver transplantation 210
Immune inflammation indicators and ALBI score to predict liver cancer in HCV-patients treated with direct-acting antivirals 210
Comparison between alcohol- and hepatitis C virus-related hepatocellular carcinoma: clinical presentation, treatments and outcome. 209
A case of inflammatory ascites. 209
Application of the Intermediate-Stage Subclassification to Patients with Untreated Hepatocellular Carcinoma 208
Affidabilità della combinazione di angioecografia perfusionale ed altre tecniche di imaging nella valutazione della trombosi portale in pazienti con epatocarcinoma (HCC) candidati al trapianto di fegato 208
Comparison of International Guidelines for Noninvasive Diagnosis of Hepatocellular Carcinoma 206
Correlation between LDH levels and response to sorafenib in HCC patients: an analysis of the ITA.LI.CA. database 205
Analysis of risk factors for early hepatic artery thrombosis after liver transplantation. Possible contribution of reperfusion in the early morning. 204
Extracorporeal Detoxification for Hepatic Failure Using Molecular Adsorbent Recirculating System: Depurative Efficiency and Clinical Results in a Long-Term Follow-Up 204
Long term follow-up and outcome of liver transplantation for alcoholic liver disease: a single center case-control study 204
Corrigendum: Vidatox 30 CH has tumor activating effect in hepatocellular carcinoma (Scientific Reports (2017) 7 (44685) DOI: 10.1038/srep44685) 203
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 203
Assessment of liver fibrosis in trnsplant recipients with recurrent HCV infection: Usefulness of transient elastography. 202
Development and Validation of a New Prognostic System for Patients with Hepatocellular Carcinoma 201
Celiac disease diagnosed through screening programs in at-risk adults is not associated with worse adherence to the gluten-free diet and might protect from osteopenia/osteoporosis 201
Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma. 200
Impiego clinico del “Fegato Artificiale” MARS: effetti sulle citochine e sui fattori di crescita 199
Consensus on the current use of sorafenib for the treatment of hepatocellular carcinoma. 199
Artificial neural network is superior to MELD in predicting mortality of patients with end-stage liver disease. 198
Economic Consequences of Investing in Anti-HCV Antiviral Treatment from the Italian NHS Perspective: A Real-World-Based Analysis of PITER Data 197
Clinical and diagnostic aspects of gluten related disorders 194
Conditional survival after hepatic resection for hepatocellular carcinoma in cirrhotic patients. 194
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 194
Clinical application of artificial liver support with the Molecular Adsorbent Recirculating System (MARS): impact on cytokines and growth factors 194
A case of intractable pruritus in Turner's syndrome successfully treated with molecular adsorbent recirculating system. 193
A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. 193
Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals 193
Linee guida A.I.S.F. per l'ipertensione portale. 192
Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. 192
Quantification of enhancement of focal liver lesions during contrast-enhanced ultrasound (CEUS). Analysis of ten selected frames is more simple but as reliable as the analysis of the entire loop for most parameters. 192
Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. 192
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma 192
Corrigendum to “Differences in liver stiffness values obtained with new ultrasound elastography machines and fibroscan: A comparative study” [Dig. Liver Dis. 49 (2017) 802–808](S1590865817302463)(10.1016/j.dld.2017.03.001) 192
Basi scientifiche per la definizione delle linee guida in ambito clinico per l’epatocarcinoma. 191
Molecular and proteomic insight into Notch1 characterization in hepatocellular carcinoma 191
Contrast-enhanced ultrasonography features of extramedullary hematopoiesis presenting as a presacral mass: an update of the literature. 190
Contrast-enhanced ultrasonography to diagnose complicated acute cholecystitis 190
Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. 189
Detoxification of bilirubin and bile acids with intermittent coupled plasmafiltration and adsorption in liver failure (HERCOLE study) 189
Impact of gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance on the non-invasive diagnosis of small hepatocellular carcinoma: a prospective study 188
ASSOCIATIONS OF THE -174 G/C INTERLEUKIN-6 GENE PROMOTER POLYMORPHISM WITH SERUM INTERLEUKIN -6 AND MORTALITY IN THE ELDERLY 188
Characterization of focal liver lesions with contrast-enhanced ultrasound. 187
Comparison of recurrence of hepatocellular carcinoma after resection in patients with cirrhosis to its occurrence in a surveilled cirrhotic population. 186
Thorough assessment of portal venous thrombosis in patients with HCC allows adequate selection of candidates for liver transplantation 186
Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver. 185
In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2. 185
CDKN1C/P57 Is Regulated by the Notch Target Gene Hes1 and Induces Senescence in Human Hepatocellular Carcinoma. 184
The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. 183
Gout, allopurinol intake and clinical outcomes in the hospitalized multimorbid elderly. 183
A relative deficiency of lysosomal acid lypase activity characterizes non-alcoholic fatty liver disease 183
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis. 183
Characterization of small nodules in cirrhosis by assessment of vascularity: the problem of hypovascular hepatocellular carcinoma. 182
Cholangiocarcinoma in Cirrhosis: Value of Hepatocyte Specific Magnetic Resonance Imaging 182
Stadiazione epatica dei carcinomi gastrointestinali di prima diagnosi mediante angioecografia perfusionale. Confronto con TC spirale ed ecografia convenzionale. 181
Real time contrast enhanced ultrasonography in detection of liver metastases from gastrointestinal cancer 181
DIAGNOSTIC ACCURACY OF LIVER AND SPLEEN STIFFNESS MEASUREMENT FOR PORTAL HYPERTENSION USING BIDIMENSIONAL SHEAR WEAVE ELASTOGRAPHY 181
Characterization of Small Nodules (1-3 cm) in Cirrhosis. The role of Perfusional Angiosonography, Spiral Computed Tomography and Double Contrast Magnetic Resonance 181
Cost analysis of recall strategies for non-invasive diagnosis of small hepatocellular carcinoma. 180
Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. 179
Brain and kidney, victims of atrial microembolism in elderly hospitalized patients? Data from the REPOSI study. 179
Response rate and clinical outcome of HCC after first and repeated cTACE performed "on demand". 179
The epigenetically regulated miR-494 associates with stem-cell phenotype and induces sorafenib resistance in hepatocellular carcinoma 179
Heterogeneity of patients with intermediate (BCLC B) Hepatocellular Carcinoma: proposal for a subclassification to facilitate treatment decisions 176
Totale 21.782
Salva come PNG Salva come JPEG
Categoria #
all - tutte 135.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 135.549
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20212.327 0 0 0 0 0 0 0 0 0 282 220 1.825
2021/20226.466 775 251 385 523 573 373 153 376 206 370 1.505 976
2022/20236.532 742 918 314 838 411 483 175 314 1.176 170 535 456
2023/20241.653 139 292 111 167 145 366 87 85 72 94 52 43
2024/20256.696 266 1.124 564 497 1.108 367 520 236 108 468 178 1.260
2025/202614.223 1.279 1.178 1.330 1.093 1.824 928 1.651 720 3.196 1.024 0 0
Totale 52.610